Annual Drug Patent Expirations for RHOFADE
Rhofade is a drug marketed by Mayne Pharma and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for RHOFADE.
This drug has twenty-one patent family members in thirteen countries.
The generic ingredient in RHOFADE is oxymetazoline hydrochloride. One supplier is listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
